A new standard prophylaxis for emesis caused by cisplatin? - Authors' reply
Lancet Oncol
.
2020 Mar;21(3):e129.
doi: 10.1016/S1470-2045(20)30100-5.
Authors
Hironobu Hashimoto
1
,
Takuhiro Yamaguchi
2
,
Masakazu Abe
3
Affiliations
1
Department of Pharmacy, National Cancer Center Hospital, Tokyo, Japan.
2
Division of Biostatistics, Tohoku University Graduate School of Medicine, Miyagi, Japan.
3
Department of Gynaecologic Oncology, Shizuoka Cancer Center, Sunto-gun, Shizuoka Prefecture 411-8777, Japan. Electronic address: ma.abe@scchr.jp.
PMID:
32135113
DOI:
10.1016/S1470-2045(20)30100-5
No abstract available
Publication types
Letter
Comment
MeSH terms
Antiemetics*
Antineoplastic Agents*
Cisplatin
Double-Blind Method
Humans
Nausea
Olanzapine
Vomiting
Substances
Antiemetics
Antineoplastic Agents
Olanzapine
Cisplatin